Close

Product Liability Lawyer Blog

Updated:

Artificial Knee Manufacturer Pleads Guilty to Fraud

According to a recent news article from NJ.com, the president and founder of OtisMed Corp. recently admitted to shipping hundreds of artificial knee products without FDA approval and pleaded guilty to criminal charges. Authorities are reporting defendant pleaded to guilty to three misdemeanor fraud counts related to a shipment of…

Updated:

Brinkley v. Pliva, Inc.: Defective Generic Drug Lawsuits

Brinkley v. Pliva, Inc., a defective drugs case from the United States Court of Appeals for the Eighth Circuit, involved plaintiff whose doctor prescribed the brand-name drug Reglan to treat her Gastro Esophageal Reflux Disease (GERD). Plaintiff’s pharmacist substituted the generic drug metoclopramide, which was manufactured by defendant. This occurred…

Updated:

Two Years After NECC Meningitis Outbreak, the Aftermath of The Tragedy Continues

In 2012, a meningitis outbreak was traced to a New England compounding facility. As our Boston product liability lawyers wrote at the time, multiple drugs were linked to the meningitis outbreak. More than two years later, many of the victims and their family members are still trying to get justice…

Updated:

Framingham Compounding Pharmacy Owners Charged with Murder

According to a recent news article from CBS Boston, the founders of a Framingham compounding pharmacy and 12 other employees have been charged with racketeering and second-degree murder. Court papers indicated the compounding pharmacy was only licensed to manufacture small numbers of specific drugs for individual patients. This is the…

Updated:

New Studies Examine the Appropriateness of Total Knee Replacement Surgery

A new article from the New York Times suggests that patients should be careful before agreeing to undergo total knee replacement. Patients who suffer from sore knees and have trouble getting around may give in too quickly to the temptations of having an artificial knee implanted. The device manufacturers have…

Updated:

Xarelto Plaintiffs Push For Consolidation of Numerous Lawsuits

Xarelto is a member of class of drugs known as New Oral Anticoagulants (NOACs) and has been the subject of many recent dangerous drug lawsuits. The makers of Xarelto (Bayer AG and Johnson & Johnson) produced a drug linked to serious clotting disorders, internal bleeding, and intracranial bleeding. Patients were…

Updated:

Stryker Agrees to Billion Dollar Settlement for Defective Hip Products

Stryker is one of many manufacturers working to resolve complaints arising from the sale of metal-on-metal hip implant products. According to Market Watch, Stryker has now agreed to settle many of the claims pending against the company. An estimated $1 billion will be provided to certain victims of defective hip…

Contact Us